Cookie Consent
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
From patient onboarding to chronic care pathways, below you can find pre-defined care flows built by our community of clinical leaders. You are free to reuse and adapt these flows to your needs, implement them in clinical practice and start improving outcomes in days.
The Zarit Caregiver Burden Interview (ZBI) evaluates the burden after a period of time of care giving for chronic patients.
The Victorian Institute of Sport Assessment-Patella (VISA-P) is the most condition-specific patient-reported outcome measure used to assess symptom severity in athletes with patellar tendinopathy.
The Victorian Institute of Sport Assessment-Gluteal (VISA-G) is a reliable and valid disability score for gluteal tendinopathy.
The Victorian Institute of Sport Assessment-Achilles (VISA-A) serves as a disease-specific questionnaire for measurement of Achilles tendinopathy severity.
The 10 Metre Walk Test is a performance measure used to assess walking speed in meters per second over a short distance. It can be employed to determine functional mobility, gait, and vestibular function.
The Tampa Scale for Kinesiophobia (TSK) is a self-report measure developed to assess ‘fear of movement-related pain’ in patients with musculoskeletal pain (ie, lower back pain).
The STarT Back Screening Tool (SBST) (9-item version) is a brief validated tool, designed to screen primary care patients with low back pain for prognostic indicators that are relevant to initial decision making.
The shoulder pain and disability index (SPADI) is a self-report questionnaire developed to measure the pain and disability associated with shoulder pathology.
The Simple Shoulder Test (SST) provides a standardized way of recording the function of a shoulder before and after treatment.
SF-36 is a set of generic, coherent, and easily administered quality-of-life measures.
The SF-12 questionnaire (Short Form 12) is a general health questionnaire that allows statements to be made about the patient's state of health over 8 different dimensions.
The Strengths and Difficulties Questionnaire is used to measure pro-social behaviour, emotional symptoms, conduct problems, hyperactivity and peer problems.
The Symptom Checklist 90-R (SCL-90-R) [1] is a widely applied self-assessment instrument for a broad range of mental disorders that assesses the subjective symptom burden in patients with mental disorders
The SCL-90 is a multidimensional psychopathology indicator, which reflects the extent to which the subject suffered from various psychological and/or physical complaints in the past period.
The QuickDASH uses 11 items to measure physical function and symptoms in persons with any or multiple musculoskeletal disorders of the upper limb.
The PROMIS Global-10 is a publically available global health assessment tool that allows measurements of symptoms, functioning, and healthcare-related quality of life (HRQoL) for a wide variety of chronic diseases and conditions.
The PRO2 is a Patient-reported outcome derived from the Crohn's Disease Activity Index (CDAI) and determines the current severity of Crohn’s disease.
PRO-CTCAE is a patient-reported outcome (PRO) measurement system developed to evaluate symptomatic toxicity in patients on cancer clinical trials.
The POSAS aims to measure scar quality metrics, including pigmentation, pliability, thickness, and similarity to adjacent skin architecture.
The POSAS aims to measure scar quality metrics, including pigmentation, pliability, thickness, and similarity to adjacent skin architecture.
The PHQ-9 is a validated, 9-question tool to assess for the degree of depression present in an individual.
The PHQ-2 inquires about the frequency of depressed mood and anhedonia over the past two weeks.
The PDQ-8 s a self-administered questionnaire, used to measure quality of life in persons with Parkinson’s disease.
The PCS was developed to help quantify an individual's pain experience, asking about how they feel and what they think about when they are in pain.
The Oxford Knee Score (OKS) is a 12-item patient-reported PRO specifically designed and developed to assess function and pain after total knee replacement (TKR) surgery (arthroplasty).
The Oxford Hip Score (OHS) is a 12-item patient-reported PRO specifically designed and developed to assess function and pain after total hip replacement (THP) surgery (arthroplasty).
The Oswestry Disability Index is patient-completed questionnaire which gives a subjective percentage score of level of function (disability) in activities of daily living in those rehabilitating from low back pain.
The Örebro Musculoskeletal Pain Screening Questionnaire (ÖMSPQ) was developed as a tool to assist in the early identification of yellow flags and patients risking the development of work disability due to the pain.
The Örebro Musculoskeletal Pain Questionnaire (ÖMPQ) is a ‘yellow flag’ screening tool that predicts long-term disability and failure to return to work when completed four to 12 weeks following a soft tissue injury.
The Neck Disability Index (NDI) is a modification of the Oswestry Low Back Pain Disability Index is a condition-specific functional status questionnaire with 10 items including pain, personal care, lifting, reading, headaches, concentration, work, driving, sleeping and recreation.
The Multidimensional Pain Inventory (MPI) is an easily accessible, reliable and valid self-report questionnaire that measures the impact of pain on an individual’s life, how others respond to that person’s expression of pain and the frequency at which the individual engages in specific activities of daily life.
The Mini-Mental State Exam (MMSE) is a 30-point questionnaire that's widely used test of cognitive function among the elderly.
The Mini-BESTest aims to target and identify 6 different balance control systems so that specific rehabilitation approaches can be designed for different balance deficits.
The KOOS-PS is intended to elicit people’s opinions about the difficulties they experience with activity due to problems with their knee.
The Kansas City Cardiomyopathy Questionnaire (KCCQ), a commonly used instrument for measuring health status in patients with heart faliure.
The International Prostate Symptom Score (IPSS) can be utilized to measure the severity of lower urinary tract symptoms.
The International Knee Documentation Committee (IKDC Questionnaire) is a knee-specific patient-reported outcome measure.
The IBD-Control is a rapid, reliable, valid and sensitive instrument for measuring overall disease control from the patient's perspective.
The Illness Attitudes Scale (IAS) is a self-rated measure that consists of nine subscales designed to assess fears, attitudes and beliefs associated with hypochondriacal concerns and abnormal illness behaviour.
The HOOS-PS is intended to elicit people’s opinions about the difficulties they experience with activity due to problems with their hip.
This HOOS is used to assess the patients’ opinion about their hip and associated problems.
The Harris Hip Scale (HHS) was developed for the assessment of the results of hip surgery, and is intended to evaluate various hip disabilities and methods of treatment in an adult population.
Hospital Anxiety and Depression Scale (HADS) is a screening tool that quickly and effectively identifies patients that show symptoms of depression and/or anxiety.
The General Health Questionnaire (GHQ) is a selfadministered screening questionnaire, designed for use in consulting settings aimed at detecting individuals with a diagnosable psychiatric disorder.
The GAD-7 is a self-administered patient questionnaire and used as a screening tool and severity measure for generalised anxiety disorder (GAD).
The Epworth Sleepiness Scale is widely used in the field of sleep medicine as a subjective measure of a patient's sleepiness.
The EQ-5D five-level version (EQ-5D-5L) is an instrument developed by the EuroQol group with the aim to create a generic cardinal index of health.
The 1990 introduced EQ-5D three-level version (EQ-5D-3L) is one of the most widely used instrument for measuring health-related quality of life.
The Prostate Cancer Module is a supplementary questionnaire module to be employed in conjunction with the QLQ-C30.
The EORTC-QLQ-LC29 is a questionnaire for measuring the quality of life in patients with lung cancer.
The EORTC-QLQ-LC13 is a standard instrument to assess the quality of life (QL) of lung cancer patients.
The EORTC-QLQ-BR45 is developed to assess the quality of life of colorectal cancer patients.
The EORTIC-QLQ-C30 is developed to assess the quality of life of cancer patients. It has been translated and validated into over 100 languages and is used in each year in more than 5,000 studies worldwide.
The EORTC-QLQ-BR45 is developed to assess the quality of life of breast cancer patients.
The BR-23 is a questionnaire for measuring the quality of life in patients with breast cancer, which was developed in 1996.
The Disability Rating Index (DRI) is a patient-reported outcome measure with the aim of measuring physical disability of respondents within a clinical setting.
The Central Sensitization Inventory (CSI) measures the somatic and emotional symptoms commonly seen in central sensitization syndrome (CSS).
The CPDI is an index of 24 questions designed to capture the frequency of specific phobias and stress disorders relevant to Covid-19.
The CORE Outcome Measure (CORE-OM) is a self-report measure of psychological distress designed to be administered during a course of treatment to determine treatment response.
The Constant–Murley Score (CMS) was introduced as an instrument to evaluate overall shoulder function, irrespective of diagnosis.
The COMI is a validated multidimensional questionnaire for assessing the key outcomes of importance to patients with neck problems.
The COMI is a validated multidimensional questionnaire for assessing the key outcomes of importance to patients with back problems.
The CCQ is a self-administered questionnaire specially developed to measure clinical control in patients with COPD.
The COPD Assessment Test (CAT) quantifies the impact of COPD symptoms on patients' overall health.
The Coronary Artery Disease Education Questionnaire (CADE-Q) is developed to assess patients’ knowledge about CAD.
The BREAST-Q, a patient-reported outcome instrument, quantifies the impact of cosmetic and reconstructive breast surgery.
The BMI is a convenient clinical and epidemiological metric for identifying and monitoring obesity prevalence.
The Beck Depression Inventory (BDI) is a 21-question multiple-choice self-report inventory and one of the most widely used psychometric tests for measuring the severity of depression.
The World Health Organization’s Alcohol Use Disorders Identification Test (AUDIT) is a very reliable and simple screening tool which is sensitive to early detection of risky and high risk (or hazardous and harmful) drinking.
The personality disorder care pathway supports clinicians and the patient through long term treatment and follow-up according to the ICHOM standard.
The psychotic disorder care pathway supports clinicians and the patient through long term treatment and follow-up according to the ICHOM standard.
The Parkinson care pathway supports clinicians and the patient through long term treatment and follow-up according to the ICHOM standard.
The cataracts care pathway supports clinicians and the patient through treatment and follow-up according to the ICHOM standard.
The coronary artery disease care pathway supports clinicians and the patient through long term treatment and follow-up according to the ICHOM standard.
The dementia care pathway supports clinicians and the patient through long term follow-up according to the ICHOM standard.
The overactive bladder care pathway supports clinicians and the patient through treatment and follow-up according to the ICHOM standard.
The pregnancy and childbirth care pathway supports clinicians and parents through pregnancy and follow-up after birth according to the ICHOM standard.
The diabetes care pathway supports clinicians and the patient through long term treatment and follow-up according to the ICHOM standard.
The atrial fibrillation care pathway supports clinicians and the patient through atrial fibrillation treatment and follow-up according to the ICHOM standard.
The chronic kidney disease (CKD) care pathway supports clinicians and the patient through CKD treatment and follow-up according to the ICHOM standard.
The depression & anxiety care pathway supports clinicians and the patient through depression & anxiety treatment and follow-up according to the ICHOM standard.
The depression & anxiety care pathway for children and young people supports clinicians and the patient through depression & anxiety treatment and follow-up according to the ICHOM standard.
The addiction care pathway supports clinicians and the patient through addiction treatment and follow-up according to the ICHOM standard.
The musculoskeletal triage flow offers numerous benefits that will increase efficiency on the one hand and improve the quality of care for both patient and provider on the other.
The mental health triage flow offers numerous benefits that will increase efficiency on the one hand and improve the quality of care for both patient and provider on the other.
The COVID-19 triage flow is based on the official WHO guidelines and can be started on a care organisation’s website and provides the first advice to patients based on a screening of the patient’s symptoms.
The pre-consultation care flow standardizes and automates the pre-consultation assessment and decreases the administrative burden for the care team.
The insomnia self-help program educates your patients on how they can recognise the symptoms of sleep problems and how they can manage it.
The panic self-help program educates your patients on what panic is and how they can manage it.
A self-help program for anxiety to make your patients active participants in their care journey.
The clinical guideline for a stroke is used in the Emergency Department (ED). The clinical guideline is designed and validated by Belgian ED doctors.
The clinical guideline for hyperkalemia is used in the Emergency Department (ED). The clinical guideline is designed and validated by Belgian ED doctors.
The clinical guideline for tachycardie is used in the Emergency Department (ED). The clinical guideline is designed and validated by Belgian ED doctors.
The clinical guideline for bradycardie is used in the Emergency Department (ED). The clinical guideline is designed and validated by Belgian ED doctors.
The clinical guideline for acute sepsis is used in the Emergency Department (ED). The clinical guideline is designed and validated by Belgian ED doctors.
The heart failure care pathway is based on the ICHOM Set of Patient-Centered Outcome Measures for Heart failure.
The colorectal cancer care pathway supports clinicians and the patient through cancer treatment and follow-up according to the ICHOM standard.
The prostate cancer pathway that supports clinicians and the patient through cancer treatment and follow-up according to the ICHOM standard.
The chronic pain care pathway enables a multidisciplinary, integrated treatment of chronic pain patients. It ensures every caregiver (doctors, nurses, dieticians, psychologist, etc.) is up-to-date and gets involved when required.
The covid-19 pathway helps to take pressure of the already stressed healthcare systems by supporting patients before they contact caregivers and by following up on patients after a visit to a GP or hospital.
Please try different keywords.
